| 摘要 |
The present invention relates to HIV polyprotein immunogens that find application as diagnostic reagents in the detection of HIV infection, as prophylactic or interventive vaccines against HIV infection, and as therapeutic agents in the treatment of HIV-I infection. Specifically, the present invention relates to the HIV polyprotein immunogens, gp160/p24 and gp160/p55. |
